Cairo: Alameda Healthcare Group , a leading private healthcare company in Egypt, announced today that it has selected As-Salam International Hospital - Maadi as a regional reference center for training doctors and medical staff on technological solutions from Siemens Healthineers, a global leader in medical technology. This represents a qualitative shift in the strategic partnership between the two parties.

As part of this initiative, Al Salam International Hospital - Maadi will serve as a training center and platform to showcase the latest medical technologies offered by Siemens Healthineers. The hospital will also organize specialized workshops and training courses aimed at enabling medical personnel, clients, and strategic partners in the region to learn about the latest medical solutions and their practical applications .

This initiative underscores both parties' commitment to promoting innovation, exchanging expertise, and adopting the latest medical technologies, with the aim of raising healthcare standards across the Middle East and North Africa region .

In this context, Dr. Fahad Khater, Chairman of Alameda Healthcare Group, expressed his pride in selecting Al Salam International Hospital in Maadi as a regional reference center for training on Siemens Healthineers' technological solutions. Dr. Khater added that this initiative reflects the two parties' shared vision to advance the healthcare sector by adopting the latest, high-quality technologies and providing continuing education for medical personnel. It also raises awareness among partners about the latest developments in medical technology in the region, which will contribute to building a better future for patient care .

For his part, Amr Kandil, CEO and Managing Director of Siemens Healthineers Egypt, stated that the partnership with Alameda Healthcare Group is constantly evolving and making a tangible impact. He noted that the selection of As-Salam International Hospital in Maadi as a regional reference center for training confirms the hospital's distinguished reputation and advanced infrastructure. Kandil also explained that the goal of the initiative is to provide a practical environment that enables doctors and medical staff to explore the importance of medical innovations in improving patient outcomes and raising operational efficiency, which supports both parties' mission of providing high-quality healthcare services to everyone, everywhere.

This initiative covers several fields, including medical imaging systems and advanced diagnostic and clinical solutions. The role that Al Salam International Hospital in Maadi will play as a regional reference center for training will contribute to creating a sustainable system for knowledge exchange and the application of best practices in the healthcare sector.

About Alameda Healthcare Group​

The Alameda Group is a leading healthcare provider in the Egyptian market. Its primary strategic objective is to provide citizens with the highest quality medical and therapeutic services, leveraging its extensive partnerships with major international institutions and its adoption of the latest medical technology and systems. The Alameda Group comprises 1,023 beds and 128 clinics across four leading JCI- accredited hospitals strategically located in Greater Cairo: As-Salam International Hospital in Maadi and As-Salam International Hospital in New Cairo, Dar Al Fouad Hospital in Nasr City, and Dar Al Fouad Hospital in 6th of October City. The Alameda Group also includes the Elixir Center, which specializes in gastrointestinal endoscopy, with branches in Mohandessin and Maadi. Alameda also owns the German Rehabilitation Center and the Tabibi Clinics network, a leading provider of 24/7 primary healthcare services, with branches in Downtown, Fifth Settlement, Maadi, and 6th of October City.

-I finish-

#Corporate Data

Disclaimer for the content of press releases
The content of these press releases is provided by a third-party provider. We do not assume any responsibility for, nor do we have any control over, such content. This content is provided on an 'as is' and 'as available' basis and has not been edited in any way. Neither we nor our affiliates are responsible for the accuracy, endorsement, or completeness of the opinions, views, information, or materials contained in this content.
Press releases are provided for informational purposes only; the content does not imply legal, investment, or tax advice or any opinion regarding the suitability, value, or profitability of any particular portfolio or investment strategy. We, or our affiliates, will not be liable for any errors or inaccuracies in the content, or for any actions you take based on such content. You expressly agree and acknowledge that you bear full responsibility for the use of the information contained in these press releases.
To the extent permitted by applicable law, Refinitiv, its parent, subsidiaries, affiliates, and their respective shareholders, directors, officers, employees, agents, advertisers, content providers, and licensors (collectively, the “Refinitiv Parties”) will not be liable (either jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive, or exemplary damages; This includes, but is not limited to: lost profits, lost savings or revenue, whether caused by negligence, tort, contract or other liability theories, even if the Refinitiv Parties have been advised of the possibility of any such damages and losses or had actually anticipated their occurrence.